Composites Part B Engineering, Journal Year: 2024, Volume and Issue: 291, P. 111975 - 111975
Published: Nov. 13, 2024
Language: Английский
Composites Part B Engineering, Journal Year: 2024, Volume and Issue: 291, P. 111975 - 111975
Published: Nov. 13, 2024
Language: Английский
Composites Part B Engineering, Journal Year: 2025, Volume and Issue: unknown, P. 112192 - 112192
Published: Feb. 1, 2025
Language: Английский
Citations
1Fitoterapia, Journal Year: 2025, Volume and Issue: 183, P. 106544 - 106544
Published: April 15, 2025
Language: Английский
Citations
0ACS Nano, Journal Year: 2025, Volume and Issue: unknown
Published: April 24, 2025
Bone diseases, such as bone metastases, pose significant therapeutic challenges due to the distinct physiological environment of skeletal tissues, which complicates targeted delivery nucleic acid therapeutics. Existing systems, including lipid nanoparticles (LNP) and polyethylenimine (PEI), struggle achieve precise targeting effectively. To address this issue, we developed a polymer-based bone-targeting bioreducible vector, poly[alendronic acid-co-(N,N'-bis(acryloyl)cystamine-co-4-amino-1-butanol)] (ALN-Pabol), incorporates alendronic (ALN) for targeting. The ALN-Pabol exhibited hydroxyapatite binding rate 91.1%, significantly outperforming nontargeted Pabol/miRNA (73.5%) commercial systems PEI/miRNA (58.3%) Lipofectamine 2000/miRNA (64.7%). In vivo fluorescence imaging demonstrated its superior accumulation compared controls. murine breast cancer metastasis model, ALN-Pabol/miRNA polyplex reduced tumor weight by 79.1% relative PBS controls 36.8% LNP/miRNA. Mechanistically, dissociates in high-glutathione microenvironment, releasing miRNA suppress cell proliferation promote apoptosis. Simultaneously, ALN inhibits osteoclast activity, mitigating osteolytic damage. Micro-CT analysis revealed near-complete restoration volume trabecular architecture healthy levels. This work establishes highly promising vector bone-targeted gene therapy, bridging critical gaps disease treatment expanding potential applications regeneration therapy.
Language: Английский
Citations
0Composites Part B Engineering, Journal Year: 2024, Volume and Issue: 291, P. 111976 - 111976
Published: Nov. 16, 2024
Language: Английский
Citations
2Composites Part B Engineering, Journal Year: 2024, Volume and Issue: 291, P. 111975 - 111975
Published: Nov. 13, 2024
Language: Английский
Citations
0